Biostax Corp.
BTAX
$0.01
$0.00111.11%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 288.50K | 254.30K | 268.00K | 233.10K | 248.90K |
| Depreciation & Amortization | -- | -- | 13.80K | 13.40K | 13.40K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 300.00K | 265.30K | 293.30K | 352.30K | 437.50K |
| Operating Income | -300.00K | -265.30K | -293.30K | -352.30K | -437.50K |
| Income Before Tax | -428.00K | -337.10K | -1.05M | -388.80K | -504.20K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -428.00K | -337.10K | -1.05M | -388.80K | -504.20K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -428.00K | -337.10K | -1.05M | -388.80K | -504.20K |
| EBIT | -300.00K | -265.30K | -293.30K | -352.30K | -437.50K |
| EBITDA | -286.50K | -251.80K | -279.60K | -338.50K | -424.10K |
| EPS Basic | -0.01 | 0.00 | -0.01 | 0.00 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.01 | 0.00 | -0.01 | 0.00 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 83.70M | 83.71M | 83.65M | 83.24M | 83.29M |
| Average Diluted Shares Outstanding | 83.70M | 85.78M | 83.65M | 83.24M | 83.29M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
